DONNA HENDLEY: Open Payments
NPI 1093885873 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,014 in 78 payments from 37 companies in 2025. Trend: 2023 $561 · 2024 $1,321 · 2025 $2,014
Food & beverage: $2,014
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $249 |
| AstraZeneca Pharmaceuticals LP | 5 | $234 |
| Daiichi Sankyo Inc. | 5 | $140 |
| GENZYME CORPORATION | 5 | $120 |
| ABBVIE INC. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Genentech USA, Inc. | 4 | $80 |
| Gilead Sciences, Inc. | 3 | $73 |
| Janssen Biotech, Inc. | 3 | $60 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
Products named: KEYTRUDA, IMFINZI, Enhertu, Trodelvy, ZEPZELCA, Vyloy, VENCLEXTA, DATROWAY.
Industry payments across GA — which companies pay providers there.
